Results 41 to 50 of about 24,510 (234)

Clostridioides difficile epidemiology in India

open access: yesAnaerobe, 2022
Clostridioides difficile infection (CDI) continues to affect hospitalized patients and community populations worldwide. In contrast to the substantial resources invested in the diagnosis and prevention of CDI in high-income countries, this anaerobic toxigenic bacterium has been largely overlooked in low-and-middle-income countries (LMICs) such as India,
Tanya M. Monaghan   +4 more
openaire   +2 more sources

Evaluation of the STANDARD M10 and Xpert C. difficile assays for the detection of toxigenic Clostridioides difficile in stools

open access: yesMicrobiology Spectrum
This study aims to compare the sensitivity and specificity of two Nucleic Acid Amplification Tests (NAATs), the STANDARD M10 Clostridioides difficile (M10) and the Xpert C. difficile (Xpert) assays, for the detection of toxigenic C.
Y. Roukoz-Diab   +7 more
doaj   +1 more source

Evaluation of three commercial rapid immunoassays for the diagnosis of Clostridioides difficile infection

open access: yesMicrobiology Spectrum
Current guidelines recommend the use of a two-step algorithm for the laboratory diagnosis of Clostridioides difficile infection (CDI). Several commercial rapid immunoassays that detect both GDH and toxin A/B in stool samples are available and could be ...
Hannes Bjarki Vigfússon   +3 more
doaj   +1 more source

Gut Microbiota Diversity of Preterm Neonates Is Associated With Clostridioides Difficile Colonization

open access: yesFrontiers in Cellular and Infection Microbiology, 2022
In adults, Clostridioides difficile infections are associated with alterations of the intestinal bacterial populations. Although preterm neonates (PN) are frequently colonized by C. difficile, limited data are available regarding the relationship between
Jeanne Couturier   +13 more
doaj   +1 more source

Clostridioides difficile Flagella

open access: yesInternational Journal of Molecular Sciences
Clostridioides difficile is an important pathogen for humans with a lead in nosocomial infection, but it is also more and more common in communities. Our knowledge of the pathology has historically been focused on the toxins produced by the bacteria that remain its major virulence factors.
Jean-Christophe Marvaud   +3 more
openaire   +2 more sources

Pathogenicity and virulence of Clostridioides difficile

open access: yesVirulence, 2023
Clostridioides difficile is the most common cause of nosocomial antibiotic-associated diarrhea, and is responsible for a spectrum of diseases characterized by high levels of recurrence, morbidity, and mortality. Treatment is complex, since antibiotics constitute both the main treatment and the major risk factor for infection.
Jessica E. Buddle, Robert P. Fagan
openaire   +4 more sources

Clostridioides difficile Infection: A Never-Ending Challenge [PDF]

open access: yes, 2022
The most common worldwide cause of antibiotic-associated diarrhea/colitis is the toxin-producing bacterium Clostridioides difficile [...
Petrosillo, Nicola, Nicola Petrosillo
core   +1 more source

Knowledge and experiences of nurses/technicians about Clostridioides difficile infection [PDF]

open access: yes, 2023
Ovaj završni rad istražuje znanja i iskustva medicinskih sestara/tehničara o infekciji Clostridioides difficile. Clostridioides difficile infekcija predstavlja izazov za zdravstveni sustav i zahtijeva pažljivo upravljanje radi prevencije širenja ...
Rendulić, Barbara
core   +2 more sources

Clostridioides difficile, a New “Superbug”

open access: yesMicroorganisms, 2023
Clostridioides difficile is a Gram-positive, spore-forming, anaerobic bacterium. The clinical features of C. difficile infections (CDIs) can vary, ranging from the asymptomatic carriage and mild self-limiting diarrhoea to severe and sometimes fatal pseudomembranous colitis. C.
Rumyana Markovska   +3 more
openaire   +3 more sources

Effective Dosage of Oral Vancomycin in Treatment for Initial Episode of Clostridioides difficile Infection: A Systematic Review and Meta-Analysis

open access: yesAntibiotics, 2019
Background: Oral vancomycin is a first line treatment for an initial episode of Clostridioides difficile infection. However, the comparative efficacy of different dosing regimens is lacking evidence in the current literature. Methods: We searched PubMed,
Chia-Yu Chiu   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy